• API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
  • API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
  • API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
  • API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
  • API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
  • API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast

API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 42/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung-Ibudilast
Product Name
Ibudilast
Name
Ibudilast Powder
Appearance
White Powder
Color
White Color
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC UV
Shelf Life
2 Years
CAS No.
50847-11-5
Mf
C14h18n2o
MW
230.30552
Melting Point
53-54ºC
Density
1.09
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
5000kg/Month

Product Description

API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast powder Raw Powder Ibudilast
Product Description
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder IbudilastAPI CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
Product Details
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
Product name Ibudilast
Cas number 50847-11-5
Appearance White powder
MF C14H18N2O
MW 230.30552
Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS).
Application&Function
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder IbudilastIbudilas use in relapsing-remitting multiple sclerosis (RRMS). In 2016, the drug received Fast Track designation from the U.S. Food and Drug Administration (FDA) to help speed its development as an MS treatment.
Ibudilast is a potential oral treatment for all forms of multiple sclerosis (MS) and for other neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS). The drug, currently in clinical testing for these diseases, has been marketed in Japan and Korea to treat post-stroke complications and bronchial asthma for over two decades.
Specification
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder IbudilastAPI CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder IbudilastAPI CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder IbudilastAPI CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
API CAS50847-11-5 Ibudilast Pharmaceutical Ibudilast Powder Raw Powder Ibudilast
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP